Elanco Sells Royalty, Milestone Rights For Lotilaner In Human Health To Blackstone For $295 Mln Cash
5/5 12:51
(RTTNews) - Elanco Animal Health Inc. (ELAN) announced Monday the sale of certain royalties and commercial milestones associated with XDEMVY (lotilaner ophthalmic solution) 0.25%, for the human health application of lotilaner, to alternative asset manager Blackstone Inc. (BX) for...